Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept for CNV in Presumed Ocular Histoplasmosis Syndrome (HANDLE)
NCT01790893Phase 2Unknown
- Start
- Mar 2013
- Primary completion
- Aug 2014
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in choroidal neovascularization (CNV). Status: unknown.
02
Drugs
aflibercept
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT01790893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790893.